rufloxacin has been researched along with Bacterial Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliaro, A | 1 |
| Choi, EC; Choi, KH; Hong, JS; Kim, SK; Lee, DK; Yoon, SJ | 1 |
| Bischoff, W; Boerema, JB; Focht, J; Naber, KG | 1 |
| Colombrita, D; Foresti, I; Peroni, L; Pinsi, G; Pirali, F; Ravizzola, G; Turano, A | 1 |
1 trial(s) available for rufloxacin and Bacterial Disease
| Article | Year |
|---|---|
An open multicentre study on the efficacy and safety of rufloxacin in patients with chronic bacterial prostatitis.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Fluoroquinolones; Humans; Male; Middle Aged; Prostatitis; Quinolones | 1991 |
3 other study(ies) available for rufloxacin and Bacterial Disease
| Article | Year |
|---|---|
[Rufloxacin: the first quinolone, the fruit of Italian research].
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Quinolones; Tablets | 1993 |
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus | 1997 |
Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Female; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections; Skin Diseases, Infectious | 1989 |